We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$38.3B
AUM Growth
-$2.87B
Cap. Flow
-$3.32B
Cap. Flow %
-8.66%
Top 10 Hldgs %
40.1%
Holding
738
New
76
Increased
139
Reduced
316
Closed
180

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$301M
2
JPM icon
JPMorgan Chase
JPM
+$284M
3
WFC icon
Wells Fargo
WFC
+$279M
4
PM icon
Philip Morris
PM
+$224M
5
CSCO icon
Cisco
CSCO
+$185M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$630M
2
CVX icon
Chevron
CVX
+$444M
3
KO icon
Coca-Cola
KO
+$414M
4
MRK icon
Merck
MRK
+$388M
5
PEP icon
PepsiCo
PEP
+$341M

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Healthcare 20.79%
3 Consumer Staples 19.28%
4 Communication Services 6.05%
5 Industrials 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
51
TJX Companies
TJX
$173B
$150M 0.39%
4,955,028
+1,418,192
+40% +$42.9M
GIS icon
52
General Mills
GIS
$19.5B
$150M 0.39%
2,890,462
-165,657
-5% -$8.2M
MA icon
53
Mastercard
MA
$487B
$150M 0.39%
2,004,221
-416,989
-17% -$32.6M
PCP
54
DELISTED
PRECISION CASTPARTS CORP
PCP
$148M 0.38%
583,782
+319,902
+121% +$82.8M
BIIB icon
55
Biogen
BIIB
$29.5B
$146M 0.38%
476,999
+340,768
+250% +$108M
VALE.P
56
DELISTED
Vale S A
VALE.P
$146M 0.38%
11,706,003
-1,038,000
-8% -$12.7M
MRK icon
57
Merck
MRK
$323B
$143M 0.37%
2,639,994
-7,489,278
-74% -$388M
AGN
58
DELISTED
Allergan Inc
AGN
$137M 0.36%
1,101,751
+373,757
+51% +$45.5M
INTU icon
59
Intuit
INTU
$83.1B
$127M 0.33%
1,637,156
-71,778
-4% -$5.48M
KMB icon
60
Kimberly-Clark
KMB
$37B
$125M 0.33%
1,186,743
-650,327
-35% -$67.3M
CVS icon
61
CVS Health
CVS
$137B
$123M 0.32%
1,649,081
-1,696,273
-51% -$120M
AMX icon
62
America Movil
AMX
$77.1B
$120M 0.31%
6,040,780
-1,061,900
-15% -$22M
ADBE icon
63
Adobe
ADBE
$94.5B
$108M 0.28%
1,635,496
+213,912
+15% +$13.7M
HUM icon
64
Humana
HUM
$45.8B
$102M 0.27%
904,557
+732,273
+425% +$76.3M
LO
65
DELISTED
LORILLARD INC COM STK
LO
$100M 0.26%
1,853,478
-1,404,034
-43% -$70.6M
LH icon
66
Labcorp
LH
$24.7B
$94.9M 0.25%
1,124,556
-173,617
-13% -$13.8M
GPC icon
67
Genuine Parts
GPC
$17.6B
$92.8M 0.24%
1,067,986
+350,644
+49% +$29.6M
SKM icon
68
SK Telecom
SKM
$13.5B
$88.3M 0.23%
2,375,770
+39,950
+2% +$1.46M
ITUB icon
69
Itaú Unibanco
ITUB
$92.3B
$88.1M 0.23%
16,269,478
-1,758,231
-10% -$8.39M
VFC icon
70
VF Corp
VFC
$6.72B
$86.4M 0.23%
1,482,374
+1,121,286
+311% +$63.2M
GWW icon
71
W.W. Grainger
GWW
$66B
$86.2M 0.23%
341,365
+98,655
+41% +$24.6M
BIDU icon
72
Baidu
BIDU
$35.8B
$84.4M 0.22%
554,195
-351,500
-39% -$58.8M
MBT
73
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$83.6M 0.22%
4,777,565
+313,280
+7% +$5.6M
VALE icon
74
Vale
VALE
$62.9B
$82M 0.21%
5,930,140
-2,798,230
-32% -$38.2M
VIV icon
75
Telefônica Brasil
VIV
$22.5B
$79.5M 0.21%
3,743,576
+912,500
+32% +$17.5M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2014 Portfolio in Review

As of Q1 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $38.3B, down 7% from $41.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $3.32B in Q1 2014, closing 180 positions and reducing 316 holdings. Its most notable exit was BROOKFIELD OFFICE PROPERTIES. INC, an estimated $37.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Xilinx Inc worth $58.7M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2014 buy was Xilinx Inc: 1,081,003 shares worth $58.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q1 2014, an estimated $301M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2014 reduction was Pfizer, cutting an estimated $630M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited BROOKFIELD OFFICE PROPERTIES. INC in Q1 2014, selling an estimated $37.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $38.3B portfolio in Q1 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 180 in Q1 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7% quarter-over-quarter to $38.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2014, filed 14 May 2014.